Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Payables (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Payables for 5 consecutive years, with $102.0 million as the latest value for Q4 2022.

  • Quarterly Payables rose 9.92% to $102.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $102.0 million through Dec 2022, up 9.92% year-over-year, with the annual reading at $102.0 million for FY2022, 9.92% up from the prior year.
  • Payables for Q4 2022 was $102.0 million at NovaBridge Biosciences, up from $92.8 million in the prior quarter.
  • The five-year high for Payables was $102.0 million in Q4 2022, with the low at $21.4 million in Q4 2018.
  • Average Payables over 5 years is $69.3 million, with a median of $84.6 million recorded in 2020.
  • The sharpest move saw Payables skyrocketed 114.94% in 2019, then increased 9.72% in 2021.
  • Over 5 years, Payables stood at $21.4 million in 2018, then surged by 114.94% to $45.9 million in 2019, then surged by 84.26% to $84.6 million in 2020, then grew by 9.72% to $92.8 million in 2021, then rose by 9.92% to $102.0 million in 2022.
  • According to Business Quant data, Payables over the past three periods came in at $102.0 million, $92.8 million, and $84.6 million for Q4 2022, Q4 2021, and Q4 2020 respectively.